Alzheimer Disease
Investigation of five polymorphic DNA markers associated with late onset Alzheimer disease
... SESHADRI , S , AL FITZPATRICK , MA IKRAM , AL DESTEFANO , V GUDNASON , M BOADA , JC BIS , AV SMITH , MM CARASSQUILLO , JC LAMBERT , D HAROLD , EM SCHRIJVERS , R RAMIREZ - LORCA , S DEBETTE , WT LONGSTRETH , AC JANSSENS , ...
12
Coping strategies among caregivers of people with Alzheimer disease: a systematic review
... = Alzheimer disease; ADAS-Cog = Alzheimer’s Disease Assessment Scale – Cognition; ADCS-ADL = Alzheimer’s Disease Cooperative Study Inventory – Activities of Daily Living; ADL = activities of ...
11
THE PERSPECTIVE OF CAREGIVER FRONT TO THE ELDERLY PEOPLE WITH ALZHEIMER DISEASE
... with Alzheimer disease ...about Alzheimer disease", "Care provided to patients with the disease", "Feelings when caring for the elderly with Alzheimer ...the ...
10
Acupuncture modulates resting state hippocampal functional connectivity in Alzheimer disease.
... Our objective is to clarify the effects of acupuncture on hippocampal connectivity in patients with Alzheimer disease (AD) using functional magnetic resonance imaging (fMRI). Twenty-eight right-handed ...
10
Alzheimer disease: development of an immunosensor for amyloid beta detection
... pre-clinical disease stages [4, ...and disease- modifying treatment efficacy in clinical drug trials in ...targets. Disease-related biomarkers can assist in patient selection, sample stratification, ...
85
Alkaloids from Stems of Esenbeckia leiocarpa Engl. (Rutaceae) as Potential Treatment for Alzheimer Disease
... Alzheimer´s disease (AD) is the most common cause of progressive cognitive dysfunction that results from a deficiency in cholinergic activity in brain ...
9
Einstein (São Paulo) vol.10 número1
... Incidence of sleep disorders in patients with Alzheimer disease.. In the above referenced article the 3rd author’s name is: Freitas MP.[r] ...
1
Dement. neuropsychol. vol.7 número1
... AD: Alzheimer disease; FTD: frontotemporal dementia; HSD: hippocampal sclerosis dementia; normal: research control subject; PSP: progressive supranuclear palsy; DNOS: dementia not otherwise ...
5
Dement. neuropsychol. vol.4 número4
... probable Alzheimer disease were randomly selected, classified and submitted to analysis according to previous professional occupation and years of formal ...
5
Proposta de uma versão brasileira para a escala ADCS-CGIC.
... for Alzheimer disease, it has become clear that traditional methods of evaluation, centered on cognition, have proved ...for Alzheimer disease (ADCS-CGIC), being the result of the recommended ...
10
Dement. neuropsychol. vol.8 número1
... AD: Alzheimer disease; AN: action naming; bvFTD: behavioral variant Frontotemporal Dementia; DLB: dementia with Lewy bodies; FA: Friedreich ataxia; HC: healthy control; LATL: left anteri[r] ...
11
The prevalence of dementia in a Portuguese community sample: a 1066 Dementia Research Group study
... Alzheimer’s disease; AGECAT: The Automated Geriatric Examination for Computer Assisted Taxonomy; CDR: Clinical Dementia Rating; CERAD: Consortium to Establish a Registry for Alzheimer’s Disease; CI: ...
11
Anticholinesterase activity evaluation of alkaloids and coumarin from stems of Conchocarpus fontanesianus
... of Alzheimer disease, this work describes the fractionation guided by evaluation of the anticholinesterase activity of the ethanolic stems extract from ...
7
Arq. NeuroPsiquiatr. vol.72 número3
... The development of CSF biomarkers of AD led to a new diagnostic definition of the disease. The use of biological markers in association with the clinical approach opens the possibility to establish a diagnosis of ...
5
Arq. NeuroPsiquiatr. vol.67 número4
... for Alzheimer’ Disease) is indicated to Alzheimer’ Disease… being un- suitable for subcortical dementia such as Parkinson’s disease de- ...Alzheimer’s disease but rarer in ...
2
Perfil da distribuição e custos dos medicamentos do componente especializado da assistência farmacêutica para doença de Alzheimer no estado do Ceará
... Alzheimer's disease is an important cause of loss of functionality and increase in direct and indirect costs ...the disease progresses to more severe forms, it becomes more prominent the cholinergic deficit ...
68
Arq. NeuroPsiquiatr. vol.72 número6
... in Alzheimer disease (AD) with cerebrovascular disease (mixed dementia), have not been ...Alzheimer’s Disease (QoL-AD) from baseline to week ...
7
Dement. neuropsychol. vol.9 número4
... An alternative to the voxel-based approach is manual segmentation of Regions of Interest (ROI). VBM does not require a priori decisions on the regions to be ana- lyzed, however, depending on the context it may prove more ...
12
Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.
... In the present study, levels of tau and p-tau significantly increased after LPS in the favorable outcome group. Consistent with our findings, increases in tau and p-tau have been reported in lumbar CSF collected after ...
12
O ENVELHECIMENTO, O CUIDADO COM O IDOSO E A DOENA DE ALZHEIMER
... de Alzheimer é um dos desafios sociais e de saúde que são mais importantes nas sociedades industrializadas, com o aumento da expectativa de vida e o progressivo envelhecimento ocorre o desenvolvimento de condições ...
17